KIDRON MIRIAM (Chief Scientific Officer) reported 1 transaction at ORAMED PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/21/2026ACC: 0001213900-26-006215
DirectorOfficer· Chief Scientific Officer
Since Feb 2019
-86.17K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
86.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−86.17K
Price / share
—
Trade value
—
% of position
6.0%
1/14/2026
1.43M→1.34M
Total
Net shares
−86.17K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | G · Gift | −86.17K | — | — | 6.0% | 1.43M | 1.34M |
| Total | −86.17K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported